clinical radiotherapeutic trial using heavy charged particles treatment human cancers accrued NUMBER patients NUMBER NUMBER treated particles NUMBER low let photons control patients heavy charged particle radiotherapy offers potential advantages improved dose localization enhanced biologic effect depending particle selected treatment target sites included selected head neck tumors ocular melanomata malignant gliomata brain carcinoma esophagus carcinoma stomach carcinoma pancreas selected juxtaspinal tumors locally advanced unresectable tumors phase iii prospective clinical trial started carcinoma pancreas using helium ions phase studies underway heavier particles carbon neon argon ions order prepare prospective phase iii trials silicon ions consideration clinical trial studies supported united states department energy national institutes health ii